TPO and Premature ovarian insufficiency: Huang et al. noted a 20% TAI prevalence in infertile women without overt hypothyroidism, and Domniz and Meirow identified anti-TPO in 24–27% of women with premature ovarian insufficiency (POI), positioning anti-TPO as a prognostic biomarker for autoimmune reproductive compromise [3,13].